TrialThe Journal of infectious diseases2025

Safety and Tolerability of a Short Course of Linezolid for the Treatment of Predominantly Moderate to Severe Tuberculous Meningitis in Adults With Human Immunodeficiency Virus.

Felicia C Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.